GHP Investment Advisors Inc. Grows Stock Position in The Cigna Group (NYSE:CI)

GHP Investment Advisors Inc. boosted its position in The Cigna Group (NYSE:CI) by 0.6% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 24,602 shares of the health services provider’s stock after acquiring an additional 156 shares during the period. GHP Investment Advisors Inc.’s holdings in The Cigna Group were worth $8,523,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Wellington Management Group LLP increased its stake in The Cigna Group by 240.8% in the fourth quarter. Wellington Management Group LLP now owns 16,674 shares of the health services provider’s stock valued at $4,993,000 after acquiring an additional 11,782 shares during the last quarter. Wealthcare Advisory Partners LLC grew its stake in shares of The Cigna Group by 7.5% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,484 shares of the health services provider’s stock worth $539,000 after buying an additional 104 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of The Cigna Group by 9.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 34,778 shares of the health services provider’s stock valued at $12,631,000 after acquiring an additional 3,066 shares in the last quarter. Transform Wealth LLC purchased a new position in The Cigna Group in the first quarter worth about $233,000. Finally, Fifth Third Wealth Advisors LLC purchased a new stake in The Cigna Group during the 1st quarter valued at $291,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director William J. Delaney III sold 2,691 shares of The Cigna Group stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the transaction, the director now owns 17,539 shares in the company, valued at approximately $6,010,264.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.60% of the stock is owned by corporate insiders.

The Cigna Group Price Performance

The Cigna Group stock traded down $1.39 during trading on Friday, reaching $316.85. The company had a trading volume of 1,390,535 shares, compared to its average volume of 1,501,591. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.71 and a current ratio of 0.71. The firm has a market capitalization of $90.01 billion, a PE ratio of 26.01, a price-to-earnings-growth ratio of 1.05 and a beta of 0.50. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $370.83. The firm’s 50-day simple moving average is $348.97 and its 200 day simple moving average is $342.93.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.42 by $0.30. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The firm had revenue of $60.52 billion for the quarter, compared to analyst estimates of $58.30 billion. During the same period in the previous year, the company posted $6.13 earnings per share. The business’s revenue was up 24.6% on a year-over-year basis. As a group, equities research analysts anticipate that The Cigna Group will post 28.48 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be given a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date is Wednesday, December 4th. The Cigna Group’s dividend payout ratio is presently 45.98%.

Analyst Ratings Changes

CI has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a research report on Wednesday. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 2nd. JPMorgan Chase & Co. lifted their price objective on The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 21st. Jefferies Financial Group upped their price objective on The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research report on Tuesday, September 17th. Finally, Barclays raised their target price on shares of The Cigna Group from $393.00 to $405.00 and gave the stock an “overweight” rating in a report on Friday, August 2nd. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $392.79.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.